期刊
TECHNOLOGY IN CANCER RESEARCH & TREATMENT
卷 9, 期 3, 页码 219-229出版社
SAGE PUBLICATIONS INC
DOI: 10.1177/153303461000900301
关键词
Gene expression profile; Cancer biomarker; Pearson correlation coefficient; Kolmogorov-Smirnov distance; Cancer diagnosis and prognosis
类别
资金
- Functional Genomics Shared Resource at the Vanderbilt-Ingram Cancer Center
- NIH [AA017437]
- SPORE [50CA95103]
- NARSAD
The large amounts of microarray data provide us a great opportunity to identify gene expression profiles (GEPs) in different tissues or disease states Disease-specific biomarker genes likely share GEPs that are distinct in disease samples as compared with normal samples The similarity of the GEPs may be evaluated by Pearson Correlation Coefficient (PCC) and the distinctness of GEPs may be assessed by Kolmogorov-Smirnov distance (KSD) In this study, we used the PCC and KSD metrics for GEPs to identify disease-specific (cancer-specific) biomarkers We first analyzed and compared GEPs using microarray datasets for smoking and lung cancer We found that the number of genes with highly different GEPs between comparing groups in smoking dataset was much larger than that in lung cancer dataset, this observation was further verified when we compared GEPs in smoking dataset with prostate cancer datasets Moreover, our Gene Ontology analysis revealed that the top ranked biomarker candidate genes for prostate cancer were highly enriched in molecular function categories such as 'cytoskeletal protein binding' and biological process categories such as 'muscle contraction' Finally, we used two genes, ACTC1 (encoding an actin subunit) and HPN (encoding hepsin), to demonstrate the feasibility of diagnosing and monitoring prostate cancer using the expression intensity histograms of marker genes In summary, our results suggested that this approach might prove promising and powerful for diagnosing and monitoring the patients who come to the clinic for screening or evaluation of a disease state including cancer
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据